Intellia Therapeutics News, Intellia Therapeutics Quote, NTLA Quote

Intellia Therapeutics (NQ:NTLA) Delayed: 11.10 -0.03 (0.27%)

Prev. Close

$11.13

Today 6M 1Y 5Y

Open

$10.96

52 Wk High

$30.40

52 Wk Low

$11.86

Day High

$11.35

Day Low

$10.92

P/E

N/A

EPS

$0.00

Volume

3,753,317

Friends, Peers and Foes (?): CRSP, BEAM, EDIT, ANVS, ALNY (more...)

ALERTS | RSS

Jul 16, 2026 02:21 AM Wolfe Research Downgrades Intellia Therapeutics (NTLA) to Underperform
Jul 6, 2026 05:02 PM Form 4 Intellia Therapeutics, For: Jul 01 Filed by: Dube Michael P
Jul 6, 2026 05:01 PM Form 4 Intellia Therapeutics, For: Jul 02 Filed by: Dulac Edward J III
Jul 6, 2026 04:05 PM Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 2, 2026 04:34 PM Form 144 Intellia Therapeutics, Filed by: Dulac Edward J III
Jun 16, 2026 06:37 AM Canaccord Reiterates Buy Rating on Intellia Therapeutics (NTLA)
Jun 15, 2026 08:52 AM Form 8-K Intellia Therapeutics, For: Jun 13
Jun 15, 2026 06:48 AM H.C. Wainwright Reiterates Buy Rating on Intellia Therapeutics (NTLA)
Jun 15, 2026 05:41 AM Intellia Therapeutics (NTLA) Reiterated at Market Outperform by Citizens
Jun 13, 2026 07:30 AM Intellia reports positive Phase 3 results for hereditary angioedema treatment

Entities mentioned with NTLA

View All Entities